Immunogenicity and Safety of Comvigen (Bivalent) Vaccine

NCT05930730 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Safety of a Single Dose of COMVIGEN Vaccine
Reactogenicity of a Single Dose of COMVIGEN Vaccine
Immunogenicity of a Single Dose of COMVIGEN Vaccine
Safety of a Single Dose of BIVALENT Pfizer/BNT Vaccine
Reactogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine
Immunogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine

Interventions

BIOLOGICAL: Comvigen (Bivalent, ChulaCov19 BNA159.2)
BIOLOGICAL: BIVALENT Pfizer/BNT vaccine

Sponsor

Chulalongkorn University

Collaborators

[object Object]